Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug. This drug has one…
The post New patent expiration for Novartis drug AMTURNIDE appeared first o…
New patent expiration for Novartis drug AMTURNIDE Read Post »
Annual Drug Patent Expirations for ASACOL+HD Asacol Hd is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for APIL drug ASACOL HD appeared first on DrugPate…
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Glaxo Grp drug BREO ELLIPTA appeared first on DrugPatent…
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are sixty-four patents…
The post New patent for Amarin Pharms drug VASCEPA appeared first on Dr…
This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suppository dosed drugs…
The post Which pharmaceutical companies have the m…
Which pharmaceutical companies have the most suppository dosed drugs? Read Post »
This chart shows the pharmaceutical companies with the most patents in Germany. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Germany? Read Post »
ASACOL HD (mesalamine) Apil Patent: 9,089,492 Expiration: Nov 15, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expi…
Drug Patent Expirations for the Week of November 14, 2021 Read Post »
Annual Drug Patent Expirations for EOVIST Eovist is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Bayer Hlthcare drug EOVIST appeared first on Dr…
New patent expiration for Bayer Hlthcare drug EOVIST Read Post »
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are ten…
The post New patent for Gilead Sciences drug BIKTARVY appeared first on DrugPa…
Annual Drug Patent Expirations for TALZENNA Talzenna is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are five patents protecting…
The post New patent for Pfizer drug TALZENNA appeared first on DrugPate…
Get new actionable insights and updates from BiotechBlog
